Correlation Between Genfit and 63633DAF1
Specify exactly 2 symbols:
By analyzing existing cross correlation between Genfit and NHI 3 01 FEB 31, you can compare the effects of market volatilities on Genfit and 63633DAF1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genfit with a short position of 63633DAF1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genfit and 63633DAF1.
Diversification Opportunities for Genfit and 63633DAF1
Average diversification
The 3 months correlation between Genfit and 63633DAF1 is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Genfit and NHI 3 01 FEB 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 63633DAF1 and Genfit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genfit are associated (or correlated) with 63633DAF1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 63633DAF1 has no effect on the direction of Genfit i.e., Genfit and 63633DAF1 go up and down completely randomly.
Pair Corralation between Genfit and 63633DAF1
Given the investment horizon of 90 days Genfit is expected to under-perform the 63633DAF1. In addition to that, Genfit is 2.75 times more volatile than NHI 3 01 FEB 31. It trades about -0.07 of its total potential returns per unit of risk. NHI 3 01 FEB 31 is currently generating about -0.09 per unit of volatility. If you would invest 8,733 in NHI 3 01 FEB 31 on December 2, 2024 and sell it today you would lose (542.00) from holding NHI 3 01 FEB 31 or give up 6.21% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Genfit vs. NHI 3 01 FEB 31
Performance |
Timeline |
Genfit |
63633DAF1 |
Genfit and 63633DAF1 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genfit and 63633DAF1
The main advantage of trading using opposite Genfit and 63633DAF1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genfit position performs unexpectedly, 63633DAF1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 63633DAF1 will offset losses from the drop in 63633DAF1's long position.Genfit vs. HCW Biologics | Genfit vs. Molecular Partners AG | Genfit vs. MediciNova | Genfit vs. Anebulo Pharmaceuticals |
63633DAF1 vs. Axcelis Technologies | 63633DAF1 vs. ioneer Ltd American | 63633DAF1 vs. Sun Country Airlines | 63633DAF1 vs. Highway Holdings Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |